Crispr Therapeutics AG vs Noble Corporation plc — how do they compare? Crispr Therapeutics AG trades at $53.9 (market cap $5.23B), while Noble Corporation plc trades at $44.25 (market cap $7.10B). The key difference: Noble Corporation plc is the larger of the two by market cap, and Noble Corporation plc pays a 4.5% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | NE | |
|---|---|---|
Market Cap | $5.23B | $7.10B |
Sector | Health | Technology |
52-Week High | $76.78 | $54.37 |
52-Week Low | $44.34 | $26.61 |
Enterprise Value | $3.65B | $8.53B |
Dividend Yield | — | 4.5% |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →